Essex Investment Management Co. LLC increased its position in shares of Revance Therapeutics, Inc. (NASDAQ:RVNC – Free Report) by 59.9% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 108,613 shares of the biopharmaceutical company’s stock after acquiring an […]